DHR

Danaher Corporation

Fundamental data last updated:June 15, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Diagnostics & Research

Exchange

NYSE

County of HQ

US

Next Earnings Date

07/28/2026

Business Summary

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

 


VALUATION

P/E

34.56

Market Cap ($M USD)

$127.47B

Forward P/E

15.66

PEG

0.13

PRICE TO SALES

5.14

PRICE TO BOOK

2.41

EV / EBITDA

21.11

5-Year Average P/E

Free Cash Flow Yield

4.15%

DCF Value

$223.79

Graham Number

$93.65

Price to FCF

24.09

EV to FCF

26.51

Earnings Yield

2.89%

FCF Yield

4.15%

DIVIDEND

Yield

0.76%

Annual Payout

$1.36

Payout Ratio

24.67%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$5.21

Next Year EPS Growth Estimate

$11.50

Next Year Revenue Growth Estimate

$3.17T

Return on Equity (ROE)

7.06%

FREE CASH FLOW

Operating Margin

20.95%

Debt-to-Equity

0.35

Piotroski F-Score

6

Altman Z-Score

3.87

Return on Invested Capital (ROIC)

6.82%

Current Ratio

1.87

Quick Ratio

1.52

Net Debt to EBITDA

1.92

Interest Coverage

20.28

Gross Profit margin

60.68%

FCF PER SHARE

$7.47

REVENUE PER SHARE

$35.00

Gainseekers Quantitative Analysis

Summary

Danaher Corporation’s valuation presents a compelling narrative for value investors. With a Forward P/E of 14.42, the market seems to underestimate its growth potential, especially when juxtaposed with a DCF value significantly higher than recent pricing. The Graham Number suggests a conservative intrinsic value, indicating potential undervaluation. Meanwhile, an Altman Z-score of 3.75 underscores financial stability, and an earnings yield of 3.13% suggests room for growth. This stock appears to be a hidden gem, mispriced relative to its intrinsic value.

AI Exposure / Tech Reliance

Operating in the Medical - Diagnostics & Research industry, Danaher is well-positioned to leverage AI advancements. The healthcare sector's increasing reliance on data analytics and diagnostics innovation aligns perfectly with Danaher's core competencies. This strategic alignment could enhance its competitive edge and operational efficiency.

The Bull Case

For GARP investors, Danaher offers a robust case. With a ROIC of 6.82% and a Piotroski F-Score of 6, the company demonstrates efficient capital allocation and solid financial health. Its FCF Yield, though modest, is supported by a strong operating margin of 20.95%, indicating effective cost management and pricing power. These metrics suggest a company capable of generating sustainable returns and capitalizing on growth opportunities.

The Bear Case

Despite its strengths, Danaher faces challenges. The Price/Sales ratio of 4.76 and Price/Book of 2.23 indicate a premium valuation, potentially limiting upside. Additionally, the stock's proximity to its 52-week high raises concerns about technical overextension. Investors should be cautious of these valuation pressures, which could hinder future appreciation.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$231.80

Institutional Ownership %

1-Year Beta

0.83

Insider Buying % (6 Mo)

Distance to 52-Week High

34.81%

Distance to 52-Week Low

10.64%

EARNINGS SURPRISE %

6.19%

50-DAY SMA

$180.61

200-DAY SMA

$204.74

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.